EHC:NYE-Encompass Health Corp (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 93.59

Change

0.00 (0.00)%

Market Cap

USD 9.52B

Volume

0.42M

Analyst Target

USD 86.07
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-28 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

N/A

USD 76.91B
DVA DaVita HealthCare Partners Inc

N/A

USD 12.66B
THC Tenet Healthcare Corporation

N/A

USD 12.31B
UHS Universal Health Services Inc

N/A

USD 11.60B
CHE Chemed Corp

N/A

USD 7.84B
CON Concentra Group Holdings Paren..

N/A

USD 2.93B
ARDT Ardent Health Partners, Inc.

N/A

USD 2.59B
NHC National HealthCare Corporatio..

N/A

USD 1.90B
BKD Brookdale Senior Living Inc

N/A

USD 1.11B
AMN AMN Healthcare Services Inc

N/A

USD 1.00B

ETFs Containing EHC

HLTH:AU VanEck Global Healthcare .. 2.33 % 0.00 %

N/A

USD 0.06B
OUSM O’Shares U.S. Small-Cap.. 1.99 % 0.48 %

N/A

USD 0.85B
JPSV Jpmorgan Active Small Cap.. 1.96 % 0.00 %

N/A

USD 0.02B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 40.27% 78% C+ 91% A-
Dividend Return 0.70% 30% F 8% B-
Total Return 40.98% 78% C+ 91% A-
Trailing 12 Months  
Capital Gain 40.27% 78% C+ 91% A-
Dividend Return 0.70% 30% F 8% B-
Total Return 40.98% 78% C+ 91% A-
Trailing 5 Years  
Capital Gain 69.76% 83% B 81% B-
Dividend Return 7.03% 63% D 19% F
Total Return 76.79% 83% B 80% B-
Average Annual (5 Year Horizon)  
Capital Gain 8.82% 39% F 62% D
Dividend Return 10.08% 43% F 59% D-
Total Return 1.26% 50% F 31% F
Risk Return Profile  
Volatility (Standard Deviation) 26.57% 83% B 41% F
Risk Adjusted Return 37.94% 57% F 52% F
Market Capitalization 9.52B 81% B- 85% B

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.